KRYS Krystal Biotech, Inc.
KRYS Krystal Biotech, Inc.
Healthcare · Biotechnology
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 neutral converging
POC $336.82 · VWAP $290.68 · +8.9% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Cluster CEO, President sold $18M, Sep 4
Coverage
1 watchlist
KRYS Price Structure
Loading timeframes…
Peers
Every watchlist KRYS belongs to, members best 30-day change first — KRYS highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Against street estimates
How KRYS's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about KRYS from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 16 days ago · Oct 1
- Krystal Biotech (KRYS) Earnings: Latest Report, Earnings Call & Financials
- KRYS: Krystal Biotech Inc - Stock Price, Quote and News - CNBC
- News Releases | Investor Relations | Krystal Biotech, Inc.
- Krystal Biotech (Nasdaq:KRYS) - Stock Analysis - Simply Wall St
- Krystal Biotech - KRYS - Stock Price & News | The Motley Fool
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
KRYS research tape
51 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.